Drugs

Resources for You

Current Drug Shortages O - R

The majority of information in this section is provided to FDA by manufacturers. Communication between FDA and the public is an essential component of preventing and mitigating drug shortages. To ensure that the information in this section is current, FDA appreciates all information and updates about shortages provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers. To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

**Listed by Generic name or Active Ingredient**

A B C D E F G H I J K L M N [O – R] S T U V W X Y Z

Ondansetron (Zofran) Injection 2 mg/mL

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP 1-888-386-1300	4 mg; 2 mL (NDC 63323-0373-02)	Available Check wholesalers for inventory.	APP currently has both presentations of Ondansetron available. Please check wholesalers for inventory. Shortage per Manufacturer: Increased demand	Demand increase for the drug.	Reverified 4/30/2013
APP 1-888-386-1300	40 mg; 20 mL (NDC 63323-0374-20)	Available Check wholesalers for inventory.		Demand increase for the drug.	Reverified 4/30/2013
Bedford Customer Service: 1-800-562-4797 20 mL vial (NDC 55390-0121-01)	2 mL vials, packages of 10 (NDC 55390-0121-10) - discontinued		Bedford has ondansetron 2 mg/mL 20 mL vials on back order and the company cannot estimate a release date. Bedford Laboratories has multiple products affected by this temporary suspension of manufacturing. Bedford will have the affected, as well as the available products, listed on their website and are updating this information as it changes. The company voluntarily suspended all manufacturing and distribution in mid-November, 2011 on a temporary basis for maintenance and requalification of equipment. Product will become available in stages as production resumes. Bedford discontinued the following products: 2 mL vials, packages of 10 (NDC 55390-0121-10) 2 mL Novaplus vials, packages of 10 (NDC 55390-0307-10) 20 mL Novaplus vials, packages of 1 (NDC 55390-0307-01) Shortage per Manufacturer: Temporary suspension of manufacturing.	Discontinuation of the manufacture of the drug.
	2 mL Novaplus vials, packages of 10 (NDC 55390-0307-10) - discontinued
	20 mL Novaplus vials, packages of 1 (NDC 55390-0307-01) - discontinued
Caraco 313-871-8400	2 mL ampules (NDC 62756-0181-01)	Caraco temporarily discontinued ondansetron injection		Discontinuation of the manufacture of the drug.
Caraco 313-871-8400	20 mL vials (NDC 62756-0182-01)	Caraco temporarily discontinued ondansetron injection		Discontinuation of the manufacture of the drug.
Hospira, Inc. Customer Service: 1-877-946-7747	2 mg/mL; 2 mL vials (NDC 0409-4755-03)	Next delivery May Estimated recovery 3Q 2013	Please check with your wholesaler for available inventory. Shortage per manufacturer: Manufacturing delay	Other	Revised 5/20/2013
	2 mg/mL; 20 mL vials (NDC 0409-4759-01)	Next delivery June Estimated recovery: 2Q 2013
	2 mg/mL; 20 mL vials (NDC 0409-4759-01)	Next delivery June Estimated recovery: 2Q 2013
West-Ward (formerly Baxter products) Customer Service: 1-800-631-2174 (Formerly a Baxter Product)	2 mg/mL, 2 mL vial (NDC 0641-6078-25)	West-Ward has limited quantities available for both presentations. West-Ward has accelerated production on this product.	West-Ward has increased production and is anticipating having additional product available in the March 2013 timeframe. Product will be made available as it is released.	Demand increase for the drug.	Reverified 5/7/2013
	2 mg/mL, 20 mL Vial (0641-6079-01)			Demand increase for the drug.	Reverified 5/7/2013
Teva 1-800-545-8800	20 mL vials (NDC 00703-7226-01)	Teva has inventory available.		Demand increase for the drug	Reverified 4/29/2013
	20 mL vials (NDC 00703-7226-03)
	2 mL vials (NDC 00703-7221-04)
	2 mL vials (NDC 00703-7221-04)
GlaxoSmithKline Customer Service: 1-888-825-5249	Zofran injection, 2 mg/mL, 2 mL vials, packages of 5 (NDC 00173-00442-02)		GlaxoSmithKline has the following available: 20 mL vial (NDC 00173-0442-00) GlaxoSmithKline has discontinued Zofran 2 mL vials	Demand increase for the drug.
GlaxoSmithKline Customer Service: 1-888-825-5249	20 mL vial (NDC 00173-0442-00)			Demand increase for the drug.
Wockhardt Customer Service: 1-800-346-6854	2 mg/mL, 2 mL vials, package of 5 (NDC 64679-0726-01)	Wockhardt has existing inventories and no backorder presently. Order via your wholesaler or distributor.	Available		Revised 3/28/2013
Wockhardt Customer Service: 1-800-346-6854	2 mg/mL, 20 mL vials, package of 1 (NDC 64679-0727-01)		Available		Revised 3/28/2013
Pfizer 1-800-533-4535	Ondansetron 4 mg/2mL x 25 count (preservative fee, latex free) NDC 0069-1340-16	Limited supply. Estimated recovery 6/1/13.		Delay in shipping of the drug.	Revised 5/7/2013
Pfizer 1-800-533-4535	40mg/20mL x 1 MDV NDC 0069-1340-02	Available		Delay in shipping of the drug.	Revised 5/7/2013
Sagent Pharmaceuticals 1-866-625-1618	2 mg/mL 2mL vial (NDC 25021-777-02)	Available			Reverified 5/13/2013
Sagent Pharmaceuticals 1-866-625-1618	2mg/mL 20mL vial (NDC 25021-782-20)	Available		Demand Increase	Reverified 5/13/2013

Oseltamivir Phosphate (Tamiflu) for Oral Suspension (6mg/mL, 60 mL) (Initial Posting Date) – 1/10/2013

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Genentech, Inc. Product support and fulfillment: 1-800-551-2231 Medical information: 1-800-821-8590	Oral Suspension 6 mg/mL 60 mL (NDC 00004-0820-09)	Genentech has Tamiflu for Oral Suspension on intermittent backorder, however supplies remain in distribution at wholesalers and pharmacies.	Tamiflu 30 mg, 45 mg and 75 mg capsules remain available. Pediatric patients over 1 year of age can be dosed correctly using the 30 mg and 45 mg capsules. For those patients who cannot swallow capsules, the capsules can be opened and the contents may be mixed with chocolate syrup or some other thick, sweet liquid, as directed by a healthcare professional. If there is difficulty locating commercial Tamiflu for Oral Suspension, FDA would like to remind healthcare professionals of the FDA-approved Instructions for the emergency compounding of an oral suspension from Tamiflu 75 mg capsules. These instructions are in the current package insert and are also posted separately on the manufacturer's website as information for healthcare professionals regarding compounding an oral suspension from Tamiflu 75 mg capsules. Alternatives to Tamiflu treatment for influenza are described on the CDC website.	Demand Increase for the Drug

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Genentech, Inc.

Product support and fulfillment: 1-800-551-2231

Medical information: 1-800-821-8590

Oral Suspension 6 mg/mL 60 mL (NDC 00004-0820-09)

Genentech has Tamiflu for Oral Suspension on intermittent backorder, however supplies remain in distribution at wholesalers and pharmacies.

Tamiflu 30 mg, 45 mg and 75 mg capsules remain available. Pediatric patients over 1 year of age can be dosed correctly using the 30 mg and 45 mg capsules.

For those patients who cannot swallow capsules, the capsules can be opened and the contents may be mixed with chocolate syrup or some other thick, sweet liquid, as directed by a healthcare professional.

If there is difficulty locating commercial Tamiflu for Oral Suspension, FDA would like to remind healthcare professionals of the FDA-approved Instructions for the emergency compounding of an oral suspension from Tamiflu 75 mg capsules. These instructions are in the current package insert and are also posted separately on the manufacturer's website as information for healthcare professionals regarding compounding an oral suspension from Tamiflu 75 mg capsules.

Alternatives to Tamiflu treatment for influenza are described on the CDC website.

Demand Increase for the Drug

Pancuronium Bromide Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	1 mg/mL; 10 mL vial (NDC 0409-4646-01)	Next delivery August Estimated Recovery: 3Q 2013	Shortage per Manufacturer: Manufacturing delay	Other	Reverified 5/20/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Hospira Inc. Customer Service:
1-877-946-7747

1 mg/mL; 10 mL vial
(NDC 0409-4646-01)

Next delivery August

Estimated Recovery: 3Q 2013

Shortage per Manufacturer:
Manufacturing delay

Other

Reverified
5/20/2013

Papaverine Hydrochloride Injection (Initial Posting Date 12/17/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
American Regent/Luitpold: 1-800-645-1706	30 mg/mL, 2 mL vial (NDC 0517-4002-25)	Company estimates a manufacturing date of 2Q 2013	Shortage per Manufacturer: Manufacturing delay	Other	Reverified 5/21/2013
American Regent/Luitpold: 1-800-645-1706	30 mg/mL, 10 mL vial (NDC 00517-4010-01)	Company estimates a manufacturing date of 2Q 2013	Shortage per Manufacturer: Manufacturing delay	Other	Reverified 5/21/2013

Peginterferon Alpha-2A (Pegasys) Injection-Prefilled Syringes (Initial Posting-3/26/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Genentech Resource Center: 1-877-436-3683	180 mcg/0.5 mL Pegasys Prefilled syringe (PFS) for single use (NDC 0004-0352-39) (NDC 0004-0357-30)	Potential limited availability of the PFS form of 180 mcg/mL Pegasys. The firm anticipates that the potential shortage of the PFS will resolve by end of June 2013.	Shortage per Manufacturer: Increased demand and manufacturing delays of the Prefilled Syringes	Other	Revised 9/24/2012
	180 mcg/0.5 mL Autoinjector for single use (NDC 0004-0365-09)	The firm has adequate supplies
	135 mcg/0.5 mL Autoinjector for single use (NDC 0004-0360-09)	The firm has adequate supplies
	180 mcg/mL Vial for single use (NDC 0004-0350-09)	The firm has adequate supplies

Pentamidine isethionate inhalant (NebuPent) (Initial posting-8/27/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP 1-888-386-1300	300 mg, SDV (NDC 63323-0877-15)	Available. Check wholesalers for inventory.	Shortage per Manufacturer: API issues	Shortage of an active ingredient	Reverified 4/30/2013

Pentamidine isethionate for injection (Pentam 300) (Initial posting-8/27/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP 1-888-386-1300	300mg, Lyophilized Powder for Injection (NDC #633230-113-10)	Available. Check wholesalers for inventory.	Shortage per Manufacturer: API issues	Shortage of an active ingredient	Reverified 4/30/2013

Pilocarpine HCL Opthalmic Gel 4% (Pilopine HS) (Initial posting-6/1/12)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Alcon Customer Service: 1-800-862-5266	PILOPINE HS (pilocarpine hydrochloride ophthalmic gel) 4% 4 gm tube: (NDC 0065-0215-35)	Unable to estimate a release date	Updates will be provided as further information becomes available. Shortage per Manufacturer: Manufacturing delay	Other

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Alcon Customer Service: 1-800-862-5266

PILOPINE HS (pilocarpine hydrochloride ophthalmic gel) 4%

4 gm tube: (NDC 0065-0215-35)

Unable to estimate a release date

Updates will be provided as further information becomes available.

Shortage per Manufacturer:
Manufacturing delay

Other

Potassium Acetate Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
American Regent/Luitpold: 1-800-645-1706	Potassium Acetate Injection, USP 2 mEq/mL	Unavailable	American Regent is currently not releasing Potassium Acetate Injection, USP.	Other	Reverified 5/21/2013
	20 mL vial, package of 25 (NDC 00517-2053-25)
	50 mL vial, package of 25 (NDC 00517-2450-25)
	100 mL Pharmacy Bulk Package, package of 25 (NDC 00517-2400-25)
Hospira, Inc. Customer Service: 1-877-946-7747	Potassium acetate injection, 2 meq/mL, 20 mL vial (NDC 00409-8183-01)	Next delivery May Estimated recovery 2Q 2013	Shortage per manufacturer: manufacturing delay.	Other	Revised 5/20/2013
Hospira, Inc. Customer Service: 1-877-946-7747	50 mL vial (NDC 00409-3294-51)	Next delivery May Estimated recovery 2Q 2013	Shortage per manufacturer: manufacturing delay.	Other	Revised 5/20/2013

Potassium Chloride Injection 2 mEq/mL (Initial posting - 5/15/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP Pharmaceuticals 1-888-386-1300	2 mEq/mL, 5 mL vials, (NDC 63323-0965-05)	Backordered. No estimated release at this time.	APP is currently back-ordered on all presentations of potassium chloride and is releasing product intermittently. Shortage per Manufacturer: Increased demand	Demand increase for the drug.	Reverified 4/30/2013
	2 mEq/mL, 10 mL vials, (NDC 63323-0965-10)	Backordered. No estimated release at this time.
	2 mEq/mL, 15 mL vials, (NDC 63323-0965-15)	Unavailable
	2 mEq/mL, 20 mL vials, (NDC 63323-0965-20)	Backordered. No estimated release at this time.
	2 mEq/mL, 30 mL vials, (NDC 63323-0967-30)	Backordered. No estimated release at this time.
B. Braun Medical Inc. Customer Service: 1-800-227-2862	2 mEq/mL, 250 mL bulk package (NDC 00264-1940-20)	Available			Revised 10/17/2012
Baxter Customer Service: 1-800-ANA-DRUG (1-800-262-3784)	10 mEq/100 mL in sterile water (NDC 00338-0709-48)	Available		Demand increase for the drug.	Reverified 5/7/2013
	20 mEq/100 mL in sterile water (NDC 00338-0705-48)	Available
	40 mEq/100 mL in sterile water (NDC 00338-0703-48)	Available
	20 mEq/50 mL in sterile water (NDC 00338-0703-41)	Available
	10 mEq/50 mL in sterile water (NDC 00338-0705-41)	Available
	20 mEq/1000 mL in lactated ringers and dextrose 5% (NDC 00338-0811-04)	Available
	20 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0803-04)	Available
	20 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0691-04)	Available
	40 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0675-04)	Available
	20 mEq/1000 mL in 5% dextrose (NDC 00338-0683-04)	Available
	40 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0695-04)	Available
	20 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0671-04)	Available
	20 mEq/500 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0671-03)	Available
	20 mEq/1000 mL in 0.45% sodium chloride (NDC 00338-0704-34)	Available
	40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0807-04)	Available
	20 mEq/500 mL in 5% dextrose and 0.2% sodium chloride (NDC 00338-0663-03)	Available
	20 mEq/1000 mL in 5% dextrose and 0.2% sodium chloride (NDC 00338-0663-04)	Available
	10 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0669-04)	Available
Hospira, Inc. Customer Service: 1-877-946-7747	2 mEq/mL; 250 mL bottle (NDC 0409-1513-02)	Next delivery September 2013 Estimated recovery: 4Q 2013	Please check with your wholesaler for available inventory. Shortage per manufacturer: Available	Demand increase for the drug/Other	Revised 5/20/2013
	2 mEq/mL; 5 mL vial (NDC 0409-6635-01)	Available
	2 mEq/mL; 15 mL vial (NDC 0409-6636-01)	Next delivery 3Q 2013 Estimated recovery 3Q 2013
	2 mEq/mL; 20 mL vial (NDC 0409-6651-06)	Available
	2 mEq/mL; 20 mL vial (NDC 0409-6653-05)	Available
	10 mEq/100 mL (NDC 0409-7074-26)	Available
	10 mEq/50 mL (NDC 00409-7075-14)	Available
	20 mEq/100 mL, (NDC00409-7075-26)	Available
	20 mEq/50 mL (NDC 00409-7077-14)	Available
	40 mEq/100 mL (NDC 00409-7077-26)	Available
	40 mEq/1000 mL (NDC 00409-7116-09)	Next delivery June Estimated recovery 2Q2013
	20 mEq/1000 mL in 0.9% NaCl (NDC 00409-7115-09)	Available
	20 mEq/1000 mL in 5% dextrose (NDC 00409-7905-09)	Available
	20 mEq/1000 mL in 5% Dex/Lact Ringers (NDC 0409-7119-09)	Available
	10 mEq/500 mL in 5% dex & 0.225% NaCl (NDC 00409-7901-03)	Available
	10 mEq/ 500 mL in 5% dex 0.45% NaCl (NDC 00409-7902-03)	Available
	20 mEq/1000 mL in 5% dex& 0.225% NaCl (NDC 00409-7901-09)	Available
	20 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 00409-7902-09)	Available
	30 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 00409-7903-09)	Available
	40 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 00409-7904-09)	Available
	10 mEq/1000 mL in 5% dex & 0.45% NaCl (NDC 00409-7993-09)	Available
	20 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 00409-7107-09)	Next delivery June Estimated recovery June

Potassium Phosphate Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. (1-877-946-7747)	3 mMol/mL, 15 mL vial (NDC 0409-7295-01)	Next delivery May Estimated recovery July	Shortage per Manufacturer: Manufacturing Delay	Other	Reverified 5/20/2013
American Regent/Luitpold 1-800-645-1706	3 mMol/mL, 5 mL vial (NDC 00517-2305-25)	Unavailable	Shortage per Manufacturer: American Regent//Luitpold is not manufacturing the 5 mL vials. American Regent//Luitpold is not manufacturing the 15 mL vials. American Regent//Luitpold is not releasing the 50 mL vials	Other	Reverified 5/21/2013
	3 mMol/mL, 15 mL vial (NDC 00517-2315-25)	Unavailable
	3 mMol/mL, 50 mL vial (NDC 00517-2350-25)	Unavailable

Procainamide HCL Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	100 mg/mL; 10 mL vial (NDC 0409-1902-01)	Next delivery May Estimated recovery 2Q 2013	Please check with your wholesaler for available inventory. Shortage per Manufacturer: manufacturing delay	Other	Reverified 5/20/2013
500 mg/mL; 2 mL vial (NDC 0409-1903-01)	Available

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Hospira Inc. Customer Service:
1-877-946-7747

100 mg/mL; 10 mL vial

(NDC 0409-1902-01)

Next delivery May

Estimated recovery 2Q 2013

Please check with your wholesaler for available inventory.

Shortage per Manufacturer: manufacturing delay

Other

Reverified
5/20/2013

500 mg/mL; 2 mL vial

(NDC 0409-1903-01)

Available

Prochlorperazine Injection (1/30/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Bedford Customer Service 1-800-562-4797	5 mg/mL, 2mL vial, 10 count (NDC 55390-0077-10)	Available. 2 mL is released to wholesalers.		Demand increase for the drug.	Reverified 5/7/2013
Bedford Customer Service 1-800-562-4797				Demand increase for the drug.	Reverified 5/7/2013

Promethazine Injection (Initial Posting Date) - 2/10/2012

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira, Inc. Customer Service: 1-877-946-7747	25 mg/mL 1 mL Carpuject (NDC 0409-2312-31)	Next delivery TBD	Shortage per Manufacturer: Production temporarily suspended due to other priorities	Other	Reverified 5/20/2013
Teva Phamaceuticals 1-800-545-8800	25 mg/mL; 1 mL vial (NDC 00703-2191-04)	Teva has all promethazine injection presentations on back order and the company cannot estimate a release date.		Requirements related to complying with good manufacturing practices	Reverified 4/29/2013
Teva Phamaceuticals 1-800-545-8800	50 mg/mL; 1 mL vial (NDC 00703-2201-04				Reverified 4/29/2013
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	Promethazine 1 mL vial, 25 mg/mL (NDC 0641-0928-25) 1 mL vial, 50 mg/mL (NDC 0641-0929-25) 1 mL ampul, 25mg/mL (NDC 0641-1495-35) 1 mL ampul, 50 mg/mL (NDC 0641-1496-35)	West-Ward is currently experiencing a small backorder situation on the Phenergan 25 mg/mL, 1 mL vial. All other Phenergan and Promethazine codes have available inventory.	West-Ward has accelerated production and will have additional units available for release by the end of January 2013. Product will be made available as it is released.	Demand increase for the drug.	Reverified 2/11/2013
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	Phenergan 1 mL vial, 25 mg/mL (NDC 0641-6084-25) 1 mL vial, 50 mg/mL (NDC 0641-6085-25) 1 mL ampul, 25mg/mL (NDC 0641-6082-25) 1 mL ampul, 50 mg/mL (NDC 0641-6083-25)			Demand increase for the drug.	Reverified 2/11/2013

Propofol (Diprivan) Injection (Initial Posting Date) - 4/5/2012

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP 1-888-386-1300	Propofol 20 mL (NDC 63323-270-25)	Weekly Releases	APP is releasing Propofol and Diprivan directly into the channel. Please check wholesalers for inventory. APP is introducing a new Diprivan 20mL in a 10/pk configuration (NDC# 63323-269-29) to replace the Diprivan 20mL in a 25/pk configuration (NDC# 63323-269-20).	Demand increase for the drug.	Reverified 4/30/2013
	Propofol 50 mL (NDC 63323-270-50)
	Propofol 100 mL (NDC 63323-270-65)
	Diprivan 20 mL (NDC 63323-269-20) -discontinue 25/pk Diprivan 20mL (NDC 63323-269-29) - introducing new 10/pk
	Diprivan 50 mL (NDC 63323-269-50)
	Diprivan 100 mL (NDC 63323-269-65)
Hospira, Inc. Customer Service: 1-877-946-7747	10 mg/mL; 20 mL (NDC 0409-4699-30)	Continuous deliveries Estimated recovery 2Q 2013	Limited allocation of 20 mL vials to contracted customers. Shortage per Manufacturer: manufacturing delay	Other	Revised 5/20/2013
	10 mg/mL; 50 mL (NDC 0409-4699-33)	Next delivery early June Estimated recovery 3Q 2013
	10 mg/mL; 100 mL (NDC 0409-4699-24)	Next delivery May Estimated recovery 2Q 2013
	10 mg/mL; 100 mL (NDC 0409-4699-24)	Next delivery May Estimated recovery 2Q 2013
APP (Fresenius Kabi) 1-888-386-1300	Fresenius Propoven 1% 20 mL glass ampule (NDC 63323-297-30)	Importation began July 2012 and will continue until all patient needs are met with approved propofol	APP in conjunction with FDA has initiated temporary importation of Fresenius Propoven 1% (propofol) injection into the US market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 614KB)for additional product and supply information. APP is releasing Fresenius Propoven 1% (propofol) directly into the channel as it becomes available. Shortage per Manufacturer: Manufacturing delay .	Other	Reverified 3/11/2013
	Fresenius Propoven 1% 50 mL SD Vial (NDC 63323-297-50)	Importation began July 2012 and will continue until all patient needs are met with approved propofol
	Fresenius Propoven 1% 100 mL SD Vial (NDC 63323-297-66)	Importation began July 2012 and will continue until all patient needs are met with approved propofol
	Fresenius Propoven 1% 100 mL SD Vial (NDC 63323-297-66)
Teva Pharmaceuticals 1-800-545-8800	10 mg/mL; 20 mL (NDC 0703-2856-04)	Teva has limited quantities of the 20 mL and 100 mL vials available.	Product will be available on allocation through next several months. Teva has established a dedicated distribution network for propofol 20 mL - product can be ordered by calling 1-855-284-3896.	Demand increase for the drug	Revised 5/1/2013
	10 mg/mL; 100 mL (NDC 0703-2859-03)

Pyridostigmine Bromide (Regnol) Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Sandoz, Inc. Customer Service 1-800-525-8747	5 mg/mL (NDC 0781-3040-95)	Available			Reverified 4/16/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Sandoz, Inc.

Customer Service

1-800-525-8747

5 mg/mL (NDC 0781-3040-95)

Available

Reverified
4/16/2013

Reserpine Tablets (Initial post date-4/17/2013)

Company	Product	Availability and Estimated Shortage Duration	Shortage Reason (per New Legislation-FDASIA)*
Sandoz, Inc. Customer Service 1-800-525-8747	0.25 mg 100s (NDC 0185-0134-01)	Next available supply August 2013	Shortage of an active ingredient
	0.25 mg 1000s (NDC 0185-0134-10)
	0.1 mg 100s (NDC 0185-0032-01)
	0.1 mg 1000s (NDC 0185-0032-10)

Rifampin for Injection (Initial posting-3/22/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Pfizer Customer Service: Pfizer Injectables 1-800-533-4535	600 mg vial (NDC 0069-0112-01)	Unavailable. Expected recovery date 6/30/2013	Shortage per Manufacturer: Manufacturing delay Please see the Dear Wholesaler and Healthcare Professional Letter (PDF – 2.78 MB) and link to the Pfizer website: http://www.pfizer.com/files/products/rifampin_dhcp_031813.pdf	Other	Reverified 5/7/2013
Pfizer Customer Service: Pfizer Injectables 1-800-533-4535	Novaplus 600 mg vial (NDC 0069-0141-01)	Unavailable. Expected recovery date 6/30/2013		Other	Reverified 5/7/2013
Sanofi 1-609-627-8500	600 mg vial (NDC 00068-0597-01)	Available	N/A	N/A
Akorn: 1-800-932-5676	600 mg vial (NDC 17478-0151-42)	Unavailable	Please check with your wholesaler for available inventory	Demand increase for the drug.	Revised 4/30/2013
Bedford Customer Service: 1-800-562-4797	600 mg vial (NDC 55390-0123-01)	Currently on backorder.	Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: Manufacturing delays	Other	Revised 4/30/2013

Current Drug Shortages Index

Drugs

Section Contents Menu

Drug Safety and Availability

Resources for You

Current Drug Shortages O - R

Links on this page: